Trends in mortality and hospital admissions of sickle cell disease patients before and after the newborn screening program in Maranhão, Brazil

Revista Brasileira de Hematologia e Hemoterapia

Volumn 37, Issue 1, 2014, Pages 12-16

  Lima, Ana Ranoy Gomes ^a   Ribeiro, Valdinar Sousa ^a   Nicolau, Dario Itapary ^b  

^a FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^b Centro de Hematologia e Hemoterapia do Maranhão HEMOMAR   (Brazil)

Author keywords

Anemia; Early diagnosis; Hospital information systems; Indicators of morbidity and mortality; Neonatal screening; Sickle cell

Indexed keywords

ARTICLE; BRAZIL; DESCRIPTIVE RESEARCH; HEALTH CARE PLANNING; HOSPITAL ADMISSION; HOSPITAL CARE; HUMAN; MORTALITY RATE; NEWBORN SCREENING; SICKLE CELL ANEMIA; TREND STUDY;

EID: 84956574116     PISSN: 15168484     EISSN: 18060870     Source Type: Journal    
DOI: 10.1016/j.bjhh.2014.11.009     Document Type: Article

References (16)

1. Frempong KO. Sickle cell disease in the United States of America and Africa. Hematology (Am Soc Hematol Educ Program). 1999:64-71.
2. Zago MA, Costa FF, Tone LG, Bottura C. Hereditary hemoglobin disorders in a Brazilian population. Hum Hered. 1983;33(2):125-9.
3. Diggs LM. Anatomic lesions in sickle cell disease. In: Abramson H, Bertles JF, Wethers DL, editors. Sickle cell disease: diagnosis, management, education, and research. St. Louis: C.V. Mosby; 1973. p. 189-229.
4. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-44.
5. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Newborn screening for sickle cell disease: effect on mortality. Pediatrics. 1988;81(6):749-55.
6. Ramalho AS, Magna LA, Paiva-e-Silva RB. A Portaria no 822/01 do Ministério da Saúde e as peculiaridades das hemoglobinopatias em saúde pública no Brasil. Cad Saúde Pública. 2003;19(4):1195-9.
7. Loureiro MM, Rozenfeld S. Epidemiologia de internações por doença falciforme no Brasil. Cad Saúde Pública. 2005;39(6):943-9.
8. Lanzkron S, Carroll CP, Haywood C Jr. Mortality rates and age at death from sickle cell disease: U.S., 1979-2005. Public Health Rep. 2013;128(2):110-6.
9. Pesquisa Nacional por Amostras em Domicílios; 2005. Available from: www.ibge.gov.br/home/estatistica/populacao./pnad2005 [cited 02.02.14].
10. Alves AL. Estudo da mortalidade por anemia falciforme. Inf Epidemiol Sus. 1996;5(4):45-53.
11. Wieranga KJ, Hampleton IR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinical based population study. Lancet. 2001;357(9257): 680-3.
12. Fernandes AP, Januário JN, Cangussu CB, Macedo DL, Viana MB. Mortality of children with sickle cell disease: a population study. J Pediatr (RioJ). 2010;86(4): 279-84.
13. Lobo CL, Ballas SK, Domingos AC, Moura PG, do Nascimento EM, Cardoso GP, et al. Newborn screening program for hemoglobinopathies in Rio de Janeiro, Brazil. Pediatr Blood Cancer. 2014;61(1):34-9.
14. Naoum PC, Alvarez F, Domingos CRB, Ferarri F, Moreira HW, Sampaio Z, et al. Hemoglobinas anormais no Brasil: prevalência e distribuição geográfica. Rev Bras Patol Clin. 1987;23(3):68-79.
15. Programa das Nações Unidas para o Desenvolvimento; 2012. Available from: www.pnud.gov.br/IDH [cited 02.02.14].
16. Ministério da Saúde Secretaria de Vigilância em Saúde. Saúde Brasil 2004-Uma análise da situação de saúde evolução da mortalidade no Brasil. Brasília, DF: SVS; 2004. p. 86-133.